Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Viridian Therapeutics, Inc.
13G/A
VRDN · 92790C104
|
5.7% |
8/14/2026
Event 6/30/2026
|
|||
| Kynam Capital Management, LP | 5.7% | ||||
| Kynam Capital Management GP, LLC | 5.7% | ||||
| Yue Tang | 5.7% | ||||
|
Vera Therapeutics, Inc.
13G/A
VERA · 92337R101
|
4.0% |
8/14/2026
Event 6/30/2026
|
|||
| Kynam Capital Management, LP | 4.0% | ||||
| Kynam Capital Management GP, LLC | 4.0% | ||||
| Yue Tang | 4.0% | ||||
|
CytomX Therapeutics, Inc.
13G/A
CTMX · 23284F105
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Kynam Capital Management, LP | 10.0% | ||||
| Kynam Capital Management GP, LLC | 10.0% | ||||
| Yue Tang | 10.0% | ||||
|
Celldex Therapeutics, Inc.
13G/A
CLDX · 15117B202
|
6.8% |
8/14/2026
Event 6/30/2026
|
|||
| Kynam Capital Management, LP | 6.8% | ||||
| Kynam Capital Management GP, LLC | 6.8% | ||||
| Yue Tang | 6.8% | ||||
|
Burning Rock Biotech Ltd
13G/A
BNR · 12233L107
|
14.0% |
5/15/2026
Event 3/31/2026
|
|||
| Kynam Capital Management, LP | 14.0% | ||||
| Kynam Capital Management GP, LLC | 14.0% | ||||
| Yue Tang | 14.0% | ||||
|
Sutro Biopharma, Inc.
13G/A
STRO · 869367102
|
5.3% |
5/15/2026
Event 3/31/2026
|
|||
| Kynam Capital Management, LP | 5.3% | ||||
| Kynam Capital Management GP, LLC | 5.3% | ||||
| Yue Tang | 5.3% | ||||
|
Cullinan Therapeutics, Inc.
13G
CGEM · 230031106
|
5.3% |
3/4/2026
Event 12/31/2025
|
|||
| Kynam Capital Management, LP | 5.3% | ||||
| Kynam Capital Management GP, LLC | 5.3% | ||||
| Yue Tang | 5.3% | ||||
|
enGene Holdings Inc.
13G/A
ENGN · 29286M105
|
2.2% |
2/17/2026
Event 12/31/2025
|
|||
| Kynam Capital Management, LP | 2.2% | ||||
| Kynam Capital Management GP, LLC | 2.2% | ||||
| Yue Tang | 2.2% | ||||
|
Cogent Biosciences, Inc.
13G/A
COGT · 19240Q201
|
4.3% |
2/17/2026
Event 12/31/2025
|
|||
| Kynam Capital Management, LP | 4.3% | ||||
| Kynam Capital Management GP, LLC | 4.3% | ||||
| Yue Tang | 4.3% | ||||
|
2seventy Bio, Inc.
13G/A
TSVT · 901384107
|
0% |
3/17/2025
Event 3/11/2025
|
|||
| Kynam Capital Management, LP | 0% | ||||
| Kynam Capital Management GP, LLC | 0% | ||||
| Yue Tang | 0% | ||||
| Kynam Global Healthcare Master Fund, LP | 0% | ||||
| Kynam Fund GP, LLC | 0% | ||||
|
Syndax Pharmaceuticals Inc
13G/A
SNDX · 87164F105
|
10.0% |
2/14/2025
Event 12/31/2024
|
|||
| Kynam Capital Management, LP | 10.0% | ||||
| Kynam Capital Management GP, LLC | 10.0% | ||||
| Yue Tang | 10.0% | ||||
|
Dynavax Technologies Corp
13G/A
DVAX · 268158201
|
4.99% |
2/14/2025
Event 12/31/2024
|
|||
| Kynam Capital Management, LP | 4.99% | ||||
| Kynam Capital Management GP, LLC | 4.99% | ||||
| Yue Tang | 4.99% | ||||